These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 16614124)

  • 1. Are there gender differences in colorectal cancer test use prevalence and correlates?
    McQueen A; Vernon SW; Meissner HI; Klabunde CN; Rakowski W
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):782-91. PubMed ID: 16614124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of colorectal cancer screening uptake among men and women in the United States.
    Meissner HI; Breen N; Klabunde CN; Vernon SW
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):389-94. PubMed ID: 16492934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer screening among Latino subgroups in the United States.
    Gorin SS; Heck JE
    Prev Med; 2005 May; 40(5):515-26. PubMed ID: 15749133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns and predictors of colorectal cancer test use in the adult U.S. population.
    Seeff LC; Nadel MR; Klabunde CN; Thompson T; Shapiro JA; Vernon SW; Coates RJ
    Cancer; 2004 May; 100(10):2093-103. PubMed ID: 15139050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer test use from the 2005 National Health Interview Survey.
    Shapiro JA; Seeff LC; Thompson TD; Nadel MR; Klabunde CN; Vernon SW
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1623-30. PubMed ID: 18628413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System.
    Seeff LC; Shapiro JA; Nadel MR
    J Fam Pract; 2002 Sep; 51(9):761-6. PubMed ID: 12366896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer.
    Schoen RE; Weissfeld JL; Trauth JM; Ling BS; Hayran M
    Am J Gastroenterol; 2002 Feb; 97(2):446-51. PubMed ID: 11866286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network.
    Young WF; McGloin J; Zittleman L; West DR; Westfall JM
    J Rural Health; 2007; 23(3):238-45. PubMed ID: 17565524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to colorectal cancer screening among Medicare consumers.
    Klabunde CN; Schenck AP; Davis WW
    Am J Prev Med; 2006 Apr; 30(4):313-9. PubMed ID: 16530618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE).
    Stock C; Brenner H
    Endoscopy; 2010 Jul; 42(7):546-56. PubMed ID: 20432204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of fecal occult blood test (FOBT) completion among low-income adults.
    Greiner KA; James AS; Born W; Hall S; Engelman KK; Okuyemi KS; Ahluwalia JS
    Prev Med; 2005 Aug; 41(2):676-84. PubMed ID: 15917068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in colorectal cancer testing among Medicare subpopulations.
    Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
    Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer test use--Maryland, 2002-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in FOBT use: evidence from a large German survey.
    Sieverding M; Matterne U; Ciccarello L
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S47-51. PubMed ID: 18368645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening in Canada: results of a national survey.
    Sewitch MJ; Fournier C; Ciampi A; Dyachenko A
    Chronic Dis Can; 2008; 29(1):9-21. PubMed ID: 19036219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.